(firstQuint)Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia.

 Micafungin (a new class of antifungal drugs) is compared to fluconazole (current standard treatment) in the treatment of patients with serious fungal infections (invasive candidiasis and candidemia) to determine its efficacy and safety.

 Patients, both male and female, aged over 16 and with confirmed disease by the doctor could be recruited and evaluated.

.

 Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia@highlight

To determine the efficacy and safety of micafungin (FK463) versus fluconazole (Diflucan) in treating patients with invasive candidiasis or candidaemia